- Home
- SPRY vs DAVE Comparison
SPRY vs DAVE Comparison
Compare SPRY & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- DAVE
- Stock Information
- Founded
- SPRY 2015
- DAVE 2017
- Country
- SPRY United States
- DAVE United States
- Employees
- SPRY N/A
- DAVE N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- DAVE Retail: Computer Software & Peripheral Equipment
- Sector
- SPRY Health Care
- DAVE Technology
- Exchange
- SPRY Nasdaq
- DAVE Nasdaq
- Market Cap
- SPRY 1.1B
- DAVE 1.1B
- IPO Year
- SPRY N/A
- DAVE N/A
- Fundamental
- Price
- SPRY $11.20
- DAVE $84.86
- Analyst Decision
- SPRY Strong Buy
- DAVE Strong Buy
- Analyst Count
- SPRY 4
- DAVE 6
- Target Price
- SPRY $24.00
- DAVE $96.50
- AVG Volume (30 Days)
- SPRY 1.4M
- DAVE 455.7K
- Earning Date
- SPRY 11-13-2024
- DAVE 03-04-2025
- Dividend Yield
- SPRY N/A
- DAVE N/A
- EPS Growth
- SPRY N/A
- DAVE N/A
- EPS
- SPRY N/A
- DAVE 3.12
- Revenue
- SPRY $2,568,000.00
- DAVE $319,355,000.00
- Revenue This Year
- SPRY $66,750.00
- DAVE $34.76
- Revenue Next Year
- SPRY $508.63
- DAVE $19.52
- P/E Ratio
- SPRY N/A
- DAVE $27.21
- Revenue Growth
- SPRY 8460.00
- DAVE 30.00
- 52 Week Low
- SPRY $5.75
- DAVE $9.01
- 52 Week High
- SPRY $18.51
- DAVE $108.50
- Technical
- Relative Strength Index (RSI)
- SPRY 40.04
- DAVE 47.44
- Support Level
- SPRY $10.20
- DAVE $82.00
- Resistance Level
- SPRY $11.60
- DAVE $94.04
- Average True Range (ATR)
- SPRY 0.67
- DAVE 6.74
- MACD
- SPRY 0.13
- DAVE -1.98
- Stochastic Oscillator
- SPRY 64.77
- DAVE 29.60
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About DAVE Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, and finding side gigs.